Related Experiment Videos
Preliminary experiences with a single-patient trials service in general practice
C J Nikles1, P P Glasziou, C B Del Mar
1Centre for General Practice, University of Queensland, Herston. j.nikles@spmed.uq.edu.au
The Medical Journal of Australia
|August 11, 2000
Summary
Single-patient trials (SPTs) in general practice successfully guided medication decisions for osteoarthritis patients. These trials help identify individual responses to treatments like NSAIDs, improving chronic condition management.
Area of Science:
- General Practice
- Pharmacology
- Rheumatology
Background:
- Chronic conditions like osteoarthritis often require long-term medication.
- Individual patient responses to medications can be highly variable.
- Optimizing medication selection is crucial for effective chronic disease management.
Purpose of the Study:
- To pilot a single-patient trials (SPTs) service within a general practice setting.
- To assess the feasibility of SPTs for improving medication decision-making in chronic conditions.
- To evaluate the utility of SPTs for identifying patient response to non-steroidal anti-inflammatory drugs (NSAIDs).
Main Methods:
- A 12-week within-patient, randomized, double-blind, placebo-controlled crossover trial comparing ibuprofen and paracetamol for osteoarthritis.
- Three pairs of two-week treatment periods were conducted for each patient.
- Outcome measures included pain, stiffness, overall arthritis assessment, medication preference, and side effects.
Main Results:
- Eight out of 14 patients completed the single-patient trials (SPTs).
- Clinically useful information aiding decision-making was obtained for all eight participants.
- Medication management was altered for six patients based on SPT outcomes.
Conclusions:
- Single-patient trials (SPTs) are feasible and can be successfully implemented in general practice.
- SPTs provide valuable data for general practitioners (GPs) to personalize medication choices for chronic conditions.
- This method is particularly useful for conditions like osteoarthritis where individual drug response varies.